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ABSTRACT 
Trichotillomania is characterized by recurrent hair pulling resulting in hair loss and has 
been shown to have a significant impact on the health and social functioning of individuals with 
the disorder. Despite a growing presence in clinical and research settings, there are relatively few 
tools available to assess the severity of Trichotillomania, and data examining the reliability and 
validity of those measures are sparse. The goal of this study was to replicate and expand on 
previous examinations of the reliability and validity of the Massachusetts General Hospital 
Hairpulling Scale, a measure of Trichotillomania severity. Similar to previous studies, results 
showed acceptable internal consistency and provided evidence for divergent validity however, 
test-retest reliability was not acceptable and evidence for convergent validity was mixed. 
Implications of these results and suggestions for the future assessment of Trichotillomania 
severity are discussed.  
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INTRODUCTION 
Trichotillomania (TTM) is a disorder that has been associated with significant health 
complications and functional impairment (Woods et al., 2006). In order to better research, assess, 
and understand the disorder, the development of reliable and valid measures of severity is vital. 
A brief review of the disorder and summary of effective treatments is provided before 
assessment tools are discussed. The purpose of this paper is to examine the reliability and 
validity of a particular self-report measure of TTM severity. 
Background 
Trichotillomania (TTM) is currently classified as an Obsessive-Compulsive Spectrum 
Disorder in the Diagnostic and Statistical Manual of Mental Disorders (5
th
 ed; DSM-5; American 
Psychiatric Association, 2013). TTM is defined as the recurrent pulling of one’s own hair, 
causing hair loss. Hair can be pulled from any site on the body but is most commonly pulled 
from the scalp, eyelashes, and eyebrows (Woods et al., 2006). Pulling sites may vary over time 
and can occur in brief episodes throughout the day or across sustained episodes lasting several 
hours. Individuals may pull from localized areas, creating bald patches or, they may distribute 
their pulling, resulting in less noticeable hair loss. 
Additional diagnostic criteria require individuals to have made repeated unsuccessful 
attempts to stop pulling (criteria B) and the pulling or resulting hair loss must cause clinically 
significant distress or impairment (criteria C). Finally, the hair pulling or hair loss must not be 
attributable to another medical condition (e.g. dermatologic) (criteria D) and must not be better 
explained by the symptoms of another mental disorder (criteria E), such as Obsessive 
Compulsive Disorder (OCD). 
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Previous versions of the DSM required that the patient report rising tension prior to 
pulling along with pleasure, relief, or gratification during or immediately after pulling (4th ed., 
text rev.; DSM-IV-TR; American Psychiatric Association, 2000). Although individuals with 
TTM commonly report these feelings, this finding has not been consistent across individuals who 
pull hair (Lochner et al., 2011; Lochner et al., 2012; du Toit, van Kradenburg, Niehaus, & Stein, 
2001). As a result, debates over the usefulness of these criteria led to their removal in the most 
recent DSM (Lochner et al., 2011; Lochner et al., 2012). It has also been argued that the word 
“noticeable”, used to describe hair loss in previous versions of the DSM, could be overly 
restrictive for individuals who distribute their pulling in an attempt to conceal hair loss (Lochner 
et al., 2012). As a result, the “noticeability” criterion was omitted from the DSM 5. 
TTM occurs in approximately 0.6% - 3.4% of the population and affects more women 
than men by a ratio of roughly 9:1 (Christenson, Pyle, & Mitchell, 1991; Duke, Keeley, Geffken, 
& Storch, 2010). A number of studies have shown individuals with TTM express functional 
impairment. (Woods et al., 2006; Diefenbach, Tolin, Hannan, Crocetto, & Worhunsky 2005; 
Stemberger, Thomas, Mansueto, & Carter, 2000). For example, in an internet sample of 1697 
self-reporting hair pullers, individuals reported significant interference in social (e.g. avoiding 
social activities, ability to maintain close relationships), occupational/academic (e.g. interference 
with job duties, difficulties performing school responsibilities), and psychosocial domains (e.g. 
elevated levels of depression and anxiety) (Woods et. al. 2006). 
TTM varies with respect to how hair is pulled and the rituals individuals perform after 
pulling. Most people tend to pull one hair at a time using their fingers; however, tools such as 
needles or tweezers may also be used. There does not appear to be any meaningful distinction 
between those who pull one hair at a time versus multiple hairs at one time (Duke et al., 2010). 
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After the hair is removed, various behaviors involving the pulled hair can occur. Some 
individuals discard the hair immediately, while others manipulate the hair in some way. 
Individuals may save the pulled hair, rub the hair between their thumb and forefinger, run the 
hair across their lips, chew or swallow the hair, or perform various other rituals (Christenson & 
Mansueto, 1999). 
Additionally, research has addressed styles of hair pulling (Flessner, Woods, Franklin, 
Keuthen, & Piacentini, 2008; du Toit et al., 2001; Christenson, Ristvedt, & Mackenzie, 1993). 
Two of these styles, automatic and focused, refer to an individual’s attentiveness to their pulling 
behavior. Automatic pulling occurs outside the awareness of the individual and usually occurs 
during sedentary activities or while attention is on another task (e.g. watching television, reading, 
talking on the phone) (Christenson et al., 1993). Focused pulling is characterized by attention to 
the pulling behavior and is thought to be an attempt to regulate negative private experiences 
(Begotka, Wetterneck, & Woods, 2004; Diefenbach, Mouton-Odum, & Stanley, 2002). Research 
investigating the extent to which individuals experience one style of pulling or the other has been 
limited. Although virtually all individuals report some level of both hair pulling styles (Flessner 
et al., 2008), estimates suggest between 15-47% of individuals characterize their pulling as 
primarily focused, whereas 19% report equal levels of automatic and focused pulling 
(Christenson, Mackenzie, & Mitchell, 1991; du Toit et al. 2001). The recognition that distinct 
styles exist has also led to an understanding that different interventions may be needed (Franklin, 
Tolin, & Diefenbach, 2006). 
Treatment studies for TTM have evaluated the efficacy of pharmacotherapy, 
psychotherapy, or a combination of both.  In adult populations, most pharmacological studies 
have evaluated antidepressants (Clomipramine, Desipramine, Fluoxetine), but opioid antagonists 
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(Naltrexone), atypical antipsychotics (Olanzapine), and a glutamate modulator (n-acetylcysteine; 
NAC) have also been studied (Christenson et al. 1991; Grant, Odlaug, & Kim, 2009; O’Sullivan 
& Christenson, 1999; Streichenwein & Thornby, 1995; van Ameringen, Mancini, Patterson, 
Bennett, & Oakman, 2010;). A meta-analysis by Bloch and colleagues (2007) reported no 
significant differences between antidepressants and control conditions. In an unpublished 
double-blind, placebo-controlled trial, Naltrexone did show significant change in one of three 
outcome measures (O’Sullivan & Christenson, 1999). However, the most promising medications 
are Olanzapine and NAC, which have both shown significant improvement in TTM symptoms 
when compared to placebo controls (van Ameringen et al., 2010; Grant et al., 2009). 
Specifically, Olanzapine showed improvement in 85% of participants compared to 17% who 
received the placebo, while NAC reported 56% of participants were “much” to “very much 
improved” compared to 16% who received the placebo. 
Although examination of pharmacological treatments has shown promise, the most 
effective treatments for TTM have used some form of habit reversal therapy (HRT) (Bloch et al., 
2007). HRT involves teaching individuals to use replacement behaviors termed competing 
responses (e.g. holding hands in lap, clenching fists) when pulling occurs or is about to occur. 
HRT for TTM also includes self-monitoring, awareness training, and stimulus control techniques 
to help individuals recognize situations where they are likely to pull and implement strategies to 
reduce pulling (e.g. removing tweezers from the bathroom, covering mirrors). In two separate 
trials where HRT was compared to medication (Clomipramine and Fluoxetine), HRT was found 
to be significantly more effective in reducing symptoms of hair pulling (Ninan, Rothbaum, 
Marsteller, Knight, & Eccard, 2000; van Minen, Hoogduin, Keijsers, Hellenbrand, & Hendriks, 
2003). 
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Regardless of modality, the foundation of effective treatment lies in the ability to define 
the problem and evaluate change. Given the myriad of ways individuals can present with TTM, it 
is important clinicians and researchers use a comprehensive set of assessment methods and 
measures to best guide treatment and report findings. Goals of assessment should include 
establishing a diagnosis, developing a functional analysis to inform treatment planning, and 
establishing symptom severity to evaluate treatment progress (Diefenbach, Tolin, Crocetto, 
Maltby, & Hannan, 2005). Although a number of measures and methods have been developed to 
assess these aspects of TTM (Diefenbach, Reitman, & Williamson, 2000; Elliott & Fuqua, 2000; 
Rothbaum, Opdyke, & Keuthen, 1999), this paper focuses on measures of severity, particularly 
of a widely used self-report measure, the Massachusetts General Hospital Hairpulling Scale 
(MGH-HS). 
Assessment of TTM Severity 
 Various methods of assessing TTM severity have been developed, but generally fall into 
one of two categories; direct and indirect. Direct methods rely on self-monitoring and 
videotaping, both of which have limitations. Self-monitoring requires the individual to record 
time spent, number of pulling episodes, or number of hairs pulled (Azrin, Nunn, & Frantz, 1980). 
Videotaping requires individuals to record themselves during times where they are likely to pull, 
usually at home, and give the tapes to a clinician. Unfortunately, individuals may not accurately 
record how much time they spent pulling during each episode or when recalling the day. 
Frequent episodes of pulling, pulling in situations where immediate recording is difficult (e.g. in 
the car), and pulling that occurs without awareness could hinder an individual’s ability to 
accurately record their own hair pulling. Likewise, videotaping allows clinicians and researchers 
to accurately assess frequency and duration of hair pulling, but is time consuming and 
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confounded by the fact that most individuals do not pull in the presence of others (Rapp, 
Miltenberger, Long, Elliott, & Lumley, 1998; Mackenzie, Ristvedt, Christenson, Lebow, & 
Mitchell, 1995). 
 Indirect methods of severity assessment include photographing affected areas, collecting 
pulled hairs, clinician-rated measures, and self-report measures. Photographing affected areas 
relies on being able to show hair loss or regrowth by taking the same picture throughout 
treatment. This method could be difficult due to lack of noticeable hair loss (i.e. distributed 
pulling) or uncomfortable due to the location of the affected area (i.e. pubic, chest, or leg 
regions). Collecting pulled hairs requires the individual to save pulled hairs, which are then 
counted or weighed. This method may be uncomfortable and the accuracy may be questionable 
(Winchel et al., 1992a). For example, there is no guarantee that collected hairs were actually 
pulled or that they were saved during each pulling episode. 
Clinician-rated measures include the Psychiatric Institute Trichotillomania Scale (PITS; 
Winchel et al., 1992b) and the National Institute of Mental Health Trichotillomania Scale 
(NIMH-TS; Swedo et al., 1989). The PITS is a 6-item scale measuring hair pulling sites, 
duration, frequency, interference, distress, and severity of hair loss. Each question is endorsed on 
an eight-point scale, with higher scores indicating more severe symptoms. The NIMH-TS is a 
clinical interview modeled scale that assesses time spent (previous week and yesterday), 
resistance, distress, and interference related to hair pulling. Resistance is measured on a five 
point response scale (0-4) and the other dimensions are measured on a six point response scale 
(0-5). These 5 items are totaled with higher scores indicating more severe symptoms. Both of 
these scales have demonstrated acceptable inter-rater agreement, but neither has shown 
acceptable internal consistency (Diefenbach et al., 2005). Likewise, although clinician rated 
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scales tend to be informative, their use in clinical and research settings could be limited by the 
time required for administration. 
Self-report measures are beneficial in that they can serve as brief, easily distributed 
assessments. Reliable and validated measures can be indispensable tools in both clinic and 
research settings. To date, there are only three self-report measures of TTM severity, one for 
children and two for adults. The two measures for adults are the Florida Obsessive Compulsive 
Inventory (FOCI; adapted for hair pulling; Storch et al., 2007) and the Massachusetts General 
Hospital Hairpulling Scale (MGH-HS; Keuthen et al., 1995). The FOCI is comprised of two 
scales. The first is a 20 item checklist asking individuals to confirm or deny the presence of 
various obsessions and compulsions. The second scale uses a 0 – 4 point likert scale to assess 
symptom severity based on loss of control, time spent, interference, distress, and avoidance. This 
scale was modified to better reflect hair pulling, replacing obsessions and compulsions with 
urges to pull and hair pulling. The MGH-HS is currently the most widely used self-report 
measure of TTM severity, despite mostly un-replicated reliability and validity statistics usually 
based on small sample sizes. 
Although the original FOCI has been established as a quality assessment of obsessions 
and compulsions (Walser, 2013), information regarding the FOCI adapted for TTM is lacking. 
Currently, only one study has used the adapted FOCI and no psychometric properties have been 
reported (Lochner et al., 2012). Because the assessment was derived from an assessment of 
OCD, similar to many TTM assessments, it overlaps considerably with the MGH-HS. Due to the 
use of the MGH-HS as the most common outcome measure of TTM, it is important to further 
explore the psychometric properties of the MGH-HS. 
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The Massachusetts General Hospital Hairpulling Scale 
Initial Development 
 The MGH-HS was developed out of need for a brief self-report measure to track changes 
in symptom severity throughout treatement (Keuthen et al., 1995). The original scale was based 
on the 10-item Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman et al., 1989) 
which is widely used to assess symptoms of OCD. The Y-BOCS was chosen because of the 
overlap between certain features of OCD and TTM (e.g. the presence of an urge prior to pulling 
and the repetitive nature of the pulling). The first half of the Y-BOCS assesses obsessions while 
the second half assesses compulsions. Urges were substituted for obsessions and three questions 
were developed to assess the frequency, intensity and perceived control over urges. Pulling 
behavior replaced the items assessing compulsions and 5 questions were developed assessing the 
frequency, efforts to resist, and actual control over pulling as well as social impact and 
associated distress of pulling. The original product was an eight item measure assessing the 
dominant features of hair pulling. 
After examining the original eight items, it was found that the social impact item was 
poorly correlated to the total score and had the lowest mean, indicating it may not be eliciting the 
intended information (Keuthen et al., 1995). As previously described, research has shown that 
individuals with TTM report interference in social, occupational, and psychological domains 
(Woods et al., 2006). However, due to the item being unable to capture the intended facet of 
TTM, it was removed. As a result, the final MGH-HS consisted of seven items, each rated on a 
scale from 0 (no symptoms) to 4 (extreme symptoms).  Individuals completing the instrument 
report the severity of their symptoms on each item over the previous week. The seven items are 
then summed to produce a score ranging from 0-28.  
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Psychometrics   
 Psychometrics is a term used to describe the statistical evaluation of psychological tests. 
More specifically, psychometrics is concerned with determining the usefulness of a given 
instrument based on core psychological concepts that include reliability and validity (Martin & 
McGlynn, 2013). The reliability of a test describes the ability of that test to produce stable and 
consistent results when the same or similar individuals are examined under the same or similar 
conditions. The validity of a test describes how well that test measures what it is intended to 
measure. A measure that is valid must also be reliable but a reliable measure does not have to be 
valid. For example, a scale that consistently weighs an object as 10 lbs. over its true weight is 
reliable in that the same result is achieved each time; however it is not valid in that it does not 
measure true weight. Some well-established analyses used in psychometric research include, but 
are not limited to, internal consistency, test-retest reliability, and construct validity. 
 Internal consistency describes the relationship between a single item of a test and the 
other items in that test and is used to determine how well the items measure an underlying 
construct. Most commonly reported as a Cronbach’s alpha, scores can range from zero to one. 
Tests that use multiple items to produce a summary score should have high internal consistency. 
Guidelines for interpreting and reporting Cronbach’s alpha usually suggest a 0.7 or above is 
“acceptable” for internal consistency. An alpha of .8 or above is considered “good” and .9 or 
above is considered “excellent.” As alpha approaches 1.0 it may become undesirable because of 
redundancy between items. It has been suggested that these guidelines may not always be 
appropriate and interpretation of Cronbach’s alpha should consider that the number of items on a 
test influences the statistic (Martin & McGlynn, 2013, Lance, Butts, & Michels, 2006). 
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Particularly, Lance et al. (2006) reviews the origins of cut off criteria for reliability and reports 
that a minimal acceptability of .8 should be used. 
 As well as being internally consistent, a test should have high test-retest reliability or be 
relatively stable over repeated administrations. Test-retest reliability can be influenced by the 
time between administrations, the relative stability of the construct being measured, and 
environmental factors. There is no standard for describing how much time should come between 
test administrations, but too short a time may be considered inadequate due to memory effects, 
while too long may appear to reflect inadequate reliability in the instrument, but may actually be 
capturing instability of what is being measured. In TTM, symptoms may appear stable day to 
day, but have greater fluctuation with more time between tests. Care should be taken in 
determining an appropriate amount of time to assess test-retest reliability. 
 Test-retest reliability is calculated by comparing the scores from the two test 
administrations and is typically reported as a Pearson correlation coefficient (r), which can range 
between zero and one. Similar to internal consistency, a value of .7 or above is considered 
“acceptable” reliability. A value of .8 or above is considered “good” and .9 or above is 
considered “excellent.” Again, caution should be taken as the coefficient approaches 1.0 in that 
the test may be resistant to change, which is problematic for a measure designed to detect 
treatment-related change. 
 Construct validity refers to the ability of a test to measure what it intends to measure. 
Evidence for or against construct validity can be found by examining the convergent and 
divergent validity of a test. Convergent validity refers to how well two tests that propose to 
measure the same thing are related. Divergent validity refers to how well two tests that propose 
to measure different things are unrelated. Theoretically, two tests that propose to measure the 
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severity of a disorder should be highly correlated without being so closely related that they are 
redundant. Likewise, two tests that propose to measure different constructs should have a low 
correlation. Replication of convergent and divergent validity continually supports or discourages 
the construct validity of a test. 
 Despite being used in clinical and research settings there is little research available on the 
psychometric properties of the MGH-HS. In the original development article, 119 consecutive 
chronic hair pullers either receiving treatment or participating in research protocols were given 
the MGH-HS (Keuthen et al., 1995). Internal consistency showed a coefficient α = .89. This 
paper also examined the factor structure of the MGH-HS and found a 1 factor structure to fit 
best, accounting for 93% of the scale score variance. 
 In a related article, 26 consecutive TTM patients were given the MGH-HS (O’Sullivan et 
al., 1995). Twenty-two of these patients were given the MGH-HS at the beginning and end of 
one of their clinical sessions, approximately one hour apart to examine test-retest reliability. All 
26 patients were given the MGH-HS 2-4 weeks apart to measure sensitivity to change. 
Additional measures included the PITS and Clinical Global Impression (CGI; Guy, 1976; a 7-
point clinician-rated summative response scale detailed later) used to assess convergent validity, 
as well as the Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988) used to assess 
divergent validity. Test-retest reliability of the MGH-HS at one hour was .97 while test-retest 
reliability was not reported for the 2-4 week administrations. Strong positive correlations were 
found with the PITS (r = .63) and the CGI (r = .75) providing evidence for convergent validity.  
The MGH-HS was showed weak, non-significant correlations with the BDI (r = .30) or the BAI 
(r = .10) providing evidence for divergent validity. 
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 Diefenbach and colleagues attempted to replicate and expand research on the 
psychometrics of various hair pulling severity measures (Diefenbach et al., 2005). Twenty-eight 
individuals diagnosed with TTM were given a variety of measures as part of an intake to a 
clinical trial. Measures included the MGH-HS, PITS, NIMH-TS, CGI, Beck Depression 
Inventory 2
nd
 Edition (BDI-II; Beck, Steer, & Brown, 1996), and State-Trait Anxiety Inventory-
Trait (STAI-T; Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). In this study the MGH-
HS had an internal consistency of α = .80 and moderately correlated with the NIMH-TS (r = .52) 
and the PITS (r = .55). Similar to the O’Sullivan et al. (1995), Diefenbach et al. (2005) found a 
weak and non-significant correlation between the MGH-HS and the BDI-II (r = .26). However, 
the MGH-HS did correlate moderately with their measure of anxiety (r = .53). 
 Across these studies, the MGH-HS seems to exhibit good internal consistency (α = .80-
.89). Although promising, there is little evidence for convergent or divergent validity. 
Furthermore, evidence that is available has been calculated from studies with relatively small 
sample sizes. Although small sample sizes are common in TTM literature, additional reports 
would add credibility to the validity of the measure. Finally, only one example can be found of 
test-retest reliability for the MGH-HS, which was measured over approximately one hour instead 
of the more traditional and practical time span of a full week as is commonly practiced in 
treatment. This study seeks to replicate and continue expanding the literature examining the 
psychometric properties of the MGH-HS in a large clinical sample of adults with TTM. 
The goals of this study are to test the internal consistency, test-retest reliability, and 
provide evidence for convergent and divergent validity of the MGH-HS. There are four 
corresponding hypotheses in this study: 1) The internal consistency of the MGH-HS will be 
acceptable with a Cronbach’s alpha above .80, 2) Test-retest reliability will be acceptable with 
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correlations between Screen and baseline and Screen and session 1 above .70, 3) the MGH-HS 
will correlate moderately to strongly with other measures of TTM severity (i.e. NIMH-TS and 
CGI), providing evidence for convergent validity, and 4) the MGH-HS will have a low 
correlation (e.g. r < .40) with measures of quality of life (i.e. Quality of Life Inventory; QOLI; 
Frisch, 1994), anxiety (BAI), and depression (BDI-II), providing evidence for divergent validity. 
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METHODS 
Participants 
Participants for this study came from a randomized controlled treatment trial examining 
the difference between two therapies for TTM in adults. The study was approved by the 
University of Wisconsin – Milwaukee Institutional Review Board and funded by the National 
Institute of Health. Entry into the study used a multi-gate process that included a brief phone 
survey, an initial in person screening assessment, and a baseline assessment before starting a 10-
week treatment protocol. Integral to study entry was a diagnosis of TTM based on DSM-IV 
criteria during the initial screening assessment. Also, participants must have been between 18 
and 65 years old, scored above 12 on the MGH-HS, had an estimated IQ above 85, been un-
medicated or on stable medication for at least 8 weeks, and not been receiving psychotherapy for 
TTM or other psychiatric condition. Participants were excluded if they met criteria for Bipolar I, 
Psychotic Disorder, current substance dependence, or minimum severity for hair pulling was not 
met. 
 A total of 117 treatment seeking adults completed the initial screening assessment. Of 
those who completed the screening, 26 either did not qualify for the study or did not return for 
the baseline assessment. Individuals who did not qualify either met exclusionary criteria (e.g. 
bipolar disorder), fell below the minimum severity for hair pulling, or did not receive a diagnosis 
of TTM. A total of 91 adults (Mage = 35.0, age range: 18-61) completed the baseline assessment. 
The baseline sample consisted of 84 females and 7 males. Seventy-six (83.5%) of the 
participants identified themselves as Caucasian, 11 (12.1%) identified themselves as African 
American, one (1.1%) identified themselves as Asian, and three (3.3%) chose not to respond.  
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Following the baseline assessment, eight additional participants did not receive the first 
session of therapy. One participant was dropped because of treatment assignment, one participant 
was dropped due to a primary mood disorder, contact was lost for one participant, and five others 
did not return for session 1 for unknown reasons. A total of 83 participants (Mage = 35.5, age 
range: 18-61) completed the self-report measures provided at the beginning of the first treatment 
session. The session 1 sample consisted of 76 females and 7 males. Seventy (84.3%) of the 
participants identified themselves as Caucasian, 10 (12.0%) identified themselves as African 
American, and 3 (3.6%) chose not to respond. Additional demographic information is provided 
in Table 1. 
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Note: GAD = Generalized Anxiety Disorder; OCD = Obsessive Compulsive Disorder; PTSD = 
Post Traumatic Stress Disorder. 
Comorbid Diagnoses were obtained using the Structured Clinical Interview for DSM-IV-TR 
during the initial screening assessment with the exception of Skin Picking (see below). Only 
current comorbid diagnoses at the time of the initial screen are listed. 
+ 
Skin Picking was assessed during the baseline assessment. Data is missing from 12 participants 
that completed the baseline assessment. 
 
 
 
Table 1: Demographic Information 
 Baseline Session 1 
 (N) (%) (N) (%) 
Comorbid Diagnoses     
      Skin Picking
+
 12 15.2 11 14.9 
      GAD 12 13.2 11 13.3 
      Specific Phobia 6 6.6 5 6.0 
      OCD 5 5.5 3 3.6 
      Major Depressive Episode 4 4.4 3 3.6 
      Social Phobia 4 4.4 4 4.8 
      Alcohol Abuse 2 2.2 2 2.4 
      Adjustment Disorder 2 2.2 2 2.4 
      Agoraphobia 2 2.2 2 2.4 
      Dysthymic Disorder 2 2.2 1 1.2 
      Panic Disorder 1 1.1 1 1.2 
      PTSD 1 1.1 1 1.2 
      Bipolar II 1 1.1 1 1.2 
Marital Status     
      Never Married 47 51.6 43 51.8 
      Married 35 38.5 32 38.6 
      Separated 1 1.1 N/A N/A 
      Divorced 8 8.8 8 9.6 
Highest Education     
      Partial High School 6 6.6 5 6.0 
      High School Graduate 9 9.9 8 9.6 
      Technical College 7 7.7 6 7.2 
      Partial College 33 36.3 30 36.1 
      College Graduate 27 29.7 26 31.3 
      Professional Degree 9 9.9 8 9.6 
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Procedure  
The MGH-HS was given during the initial screen as well as the baseline assessment and 
the beginning of each treatment session. During the baseline assessment, participants completed 
a number of other measures assessing severity of hair pulling, depressive symptoms, anxiety 
symptoms, and quality of life. The measures used for analysis are detailed below. Data from the 
91 participants who completed baseline was used to examine single time point psychometrics of 
the MGH-HS (i.e. internal consistency, convergent validity, and divergent validity). Using data 
from the individuals who completed baseline ensures a diagnosis of TTM with the minimal 
severity level required to enter the study. Test-retest reliability used data from the 91 participants 
who completed both screen and baseline and data from the 82 participants who completed both 
the initial screen and session one of treatment. 
Materials 
Massachusetts General Hospital – Hairpulling Scale (MGH-HS) 
 The MGH-HS is a 7-item self-report scale used to assess the severity of hair pulling in 
the previous week. The items specifically measure the frequency, intensity, and perceived 
control over urges, as well as the frequency, resistance, perceived control, and distress over 
pulling behaviors. Each item is scored from 0 (no symptoms) to 4 (extreme symptoms) and the 
items are summed to produce an overall severity score ranging from 0-28. 
National Institute of Mental Health – Trichotillomania Scale (NIMH-TS)  
 The NIMH-TS is comprised of 5 items administered in a clinical interview style. It was 
derived from the Y-BOCS and assesses time spent pulling in the past week, time spent pulling 
the previous day, resistance to pulling, distress, and impairment. Resistance is scored on a 1-5 
scale while the other items are scored on a 0-5 scale, with higher scores indicating more severe 
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symptoms. Scores are summed to give a measure of total severity. Previous research has shown 
the NIMH to have moderate test-retest reliability (r = .70) and good inter-rater reliability (p = 
.88) (Franklin, Edson, Ledley, & Cahill, 2011). It was also significantly correlated with the PITS 
(r = .75) and the CGI (r = .63; described below) (Diefenbach et al. 2005). 
Clinical Global Inventory – Severity (CGI-S)  
 The CGI is a 7-item clinician-rated instrument that uses a 7-point scale to assess 
symptom severity and improvement (CGI-S and CGI-I). A single rating is made for each item on 
a 1 - 7 scale. Severity scores range from 1 = normal, not at all ill to 7 = extremely ill. Scores on 
the CGI-S have been shown to be significantly correlated with the distress (r = .58) and 
impairment (r = .76) ratings on the NIMH-TS as well as the Interference (r = .67) and hair loss 
severity (r = .58) ratings on the PITS. 
Beck Anxiety Inventory (BAI)  
 The BAI is a 21 item self-report measure that assesses symptoms of anxiety experienced 
in the past week (e.g. heart pounding or racing, unable to relax). Each item is scored on a 4-point 
scale where 0 = not at all, 1 = mildly, 2 = moderately, and 3 = severely. Scores are totaled and 
can range from 0-63. The BAI has shown high internal consistency (α = 0.92) and one-week 
test–retest reliability (r = 0.75 Beck et al., 1988). 
Beck Depression Inventory – II (BDI-II)  
 The BDI-II is a 21 item self-report measure that assesses symptoms of depression 
experienced in the past two weeks. Each item is scored on a 0-3 summative scale with higher 
scores indicating more severe symptoms. Scores can range from 0-63.  The BDI-II has shown 
high internal consistency (α = .92) and test-retest reliability (r = .96; Sprinkle et al. 2002). 
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Quality Of Life Inventory (QOLI) 
 The QOLI is a 32 item self-report questionnaire that assesses satisfaction with 16 
domains of life (e.g. health, money, work). Questions are paired asking individuals to rate the 
importance (rated 0-2) and satisfaction (rated -3 - +3; no zero) with each domain. Scores for each 
domain are then calculated by multiplying the importance by the satisfaction to receive a 
weighted score. These weighted scores are added together and divided by 16 to receive a total 
raw score for quality of life. T-Scores are identified using the norms table in the manual. Internal 
consistency for the QOLI was acceptable at α = .79 and it also showed acceptable convergent 
validity. Divergent validity was significant but low (r = .25) when compared to a social 
desirability scale. 
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RESULTS 
Internal Consistency 
The means, standard deviations, and Cronbach’s alpha are presented in Table II. The 
internal consistency of the MGH-HS was shown to be in the acceptable and “good” range (α = 
0.83). Only the deletion of item 5, resistance to pulling, would increase internal consistency, 
though not enough to be considered “excellent.” 
Table 2: Descriptive Statistics and Internal Consistency of the MGH-HS 
 
Mean (SD) Cronbach’s α 
Cronbach’s α if Item 
deleted 
MGH-HS (Total) 16.98(4.65) 0.83  
      Frequency of Urges 2.23 (1.01)  0.78 
      Intensity of Urges 2.37 (0.87)  0.78 
      Control of Urges 2.54 (0.95)  0.80 
      Frequency of Pulling 2.10 (0.96)  0.80 
      Resistance to Pulling 2.22 (0.89)  0.87 
      Control of Pulling 3.21 (0.78)  0.80 
      Distress of Pulling 2.31 (1.11)  0.82 
Note: MGH-HS = Massachusetts General Hospital Hairpulling Scale 
 
Test-Retest Reliability 
The initial screen and baseline assessment were an average of 13.3 days apart (SD = 9.9, 
range: 3–85). The correlation between the MGH-HS completed at screen and baseline was r(89) 
= .482, p <.01. When the participant with the greatest timespan between screen and baseline was 
removed (i.e. 85 days), the average number of days changed to 12.5 (SD = 6.38, range: 3–39), 
but the correlation remained identical. The average time between the screen and session 1 was 
22.7 days (SD = 9.2, range: 6–56). The correlation between screen and session one was r(79) = 
.328, p < .01. 
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Construct Validity 
 Convergent and divergent validity were examined using the measures described above in 
the baseline assessment. A Pearson correlation was conducted comparing the MGH-HS to the 
continuous measures (NIMH-TS, BAI, BDI-II, and QOLI) and a Spearman correlation was used 
to compare the MGH-HS to the CGI-S. Results from the Pearson correlation are presented in the 
left column of Table III. A Shapiro-Wilk test of normality on the continuous measures revealed 
that the NIMH-TS, the measure of anxiety (BAI), and the measure of depression (BDI-II) were 
not normally distributed, which violates an assumption of the Pearson correlation. To correct for 
the non-normal distribution, a Spearman correlation was conducted (Hauke, & Kossowski, 2011) 
and results are presented in the right column of Table III with the CGI-S. 
Note: MGH-HS = Massachusetts General Hospital Hairpulling Scale; NIMH = National Institute 
of Mental Health Trichotillomania Severity Scale; BDI-II = Beck Depression Inventory 2
nd
 
Edition; BAI = Beck Anxiety Inventory; QOL = Quality of Life Inventory; CGI-S = Clinical 
Global Impression Scale. 
*
p < .05 (2-tailed) 
**
p < .01 (2-tailed) 
Results showed a moderate and statistically significant correlation between the MGH-HS 
and the NIMH-TS and a low, yet statistically significant correlation between the MGH-HS and 
CGI-S. The MGH-HS showed low correlations with the measures of anxiety and quality of life. 
The correlation between the MGH-HS and the BDI-II was also low, but statistically significant. 
Table 3: Correlational Analysis of Construct Validity 
 
Pearson Correlation 
 
Spearman Correlation 
  
 MGH-HS  MGH-HS 
NIMH-TS 0.57**  0.57** 
BAI 0.17  0.22* 
BDI-II 0.30**  0.28** 
QOL -0.16  - 
CGI-S -  0.27* 
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DISCUSSION 
 
 This study sought to examine the psychometric properties of the MGH-HS. The MGH-
HS was chosen due to its wide use as a severity measure of TTM in clinical and research settings 
and the relative paucity of evidence demonstrating acceptable reliability and validity. A strength 
of this study was the relatively large and well defined sample. Also, due to the multi-gated 
design required prior to receiving treatment, this study allowed for a unique view of fluctuations 
in TTM severity in the absence of an active intervention. Below, the hypotheses pertaining to 
each domain of psychometric properties is reviewed and relevant follow-up discussed. 
Internal Consistency  
 It was predicted that the internal consistency of the MGH-HS would be acceptable with a 
Cronbach’s alpha above .80. Similar to previous studies examining the MGH-HS, Cronbach’s 
alpha indicated good internal consistency. The deletion of any single item of the MGH-HS 
would result in a Cronbach’s alpha ranging from .78 to .87. This suggests that the seven items 
that make up the MGH are a cohesive set that measure the same underlying construct. 
Test-R etest Reliability 
 The MGH-HS was hypothesized to demonstrate acceptable test-retest reliability (i.e. r > 
.70) for administrations from screen to baseline and screen to session one of treatment. The 
proposed design of the randomized controlled trial intended to have a one week gap between the 
initial screening assessment, baseline assessment, and first treatment session. Under ideal 
circumstances, this would have allowed for a one-week and two-week examination of test-retest 
reliability following the procedures laid out by this study. However, the time between 
assessments led to a two-week and three-week examination of test-retest reliability. Results from 
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this study indicate that the MGH-HS does not possess strong temporal stability at roughly two 
and three week periods. 
The interpretation of test-retest reliability should take into account three factors that can 
influence scores over repeated administrations. These factors include environmental influences, 
time between administrations, and the relative stability of the construct being measured. With 
respect to environmental influences, the discussion of hair pulling may have increased 
participant’s self-awareness to hair pulling symptoms between assessments. When completing 
the MGH-HS the first time, participants are asked to retrospectively consider hair pulling 
symptoms they may not have focused on previously. Lack of awareness may have resulted in 
over or underestimation of hair pulling symptoms when completing the MGH-HS the first time. 
Increased awareness between assessments could have led to differences in ratings even if 
symptoms were largely unchanged. 
As for the time between administrations, the two week and three week latency likely 
reduced the test-retest reliability in comparison to earlier studies. O’Sullivan and colleagues 
showed a 0.97 correlation when administrations of the MGH-HS were one hour apart. The strong 
correlation found in their study may be misleading due to participants remembering their 
responses. Given the decrease in reliability over time, it is possible that there is an amount of 
time between administrations of the MGH-HS that would demonstrate acceptable test-retest 
reliability while minimizing memory effects. 
Lastly, test-retest reliability assumes that the construct being measured is relatively stable 
in the absence of an active intervention. However, research examining fluctuations of TTM 
symptoms across various age groups has suggested that this is not the case (Flessner et al., 2009).  
Specifically, Flessner and colleagues showed that changes in hair pulling symptoms appeared to 
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coincide with increased psychological distress or hormonal changes. Although their study 
examined hair pulling symptoms in age groups across the lifespan, results suggest hair pulling 
symptoms could fluctuate with smaller scale changes in psychological distress or hormonal 
changes that occur on a daily, weekly, or monthly basis. 
It is likely that each of the factors mentioned above had some influence that led to the 
demonstration of weak temporal stability of the MGH-HS. Unfortunately, weak temporal 
stability impacts the interpretation of treatment gains as measured by the MGH-HS. If the MGH-
HS is determined to be unreliable, it becomes difficult to conclude that changes in scores are the 
result of an intervention or natural variation in hair pulling symptoms. 
Future research would benefit from further investigation of the temporal stability of the 
MGH-HS. One suggestion is to examine test-retest reliability with one week between 
administrations. Not only is a one week time frame consistent with the completion instructions   
of the MGH-HS, it conforms to a more realistic timeframe between clinical sessions. Another 
suggestion is to conduct multiple assessments of TTM severity and analyze their test-retest 
reliability simultaneously. If the MGH-HS and another measure were to show similar changes in 
scores between administrations it would suggest that both measures are reacting to variations in 
the behavior. If the other measure was to demonstrate more stability than the MGH-HS, it would 
suggest that the MGH-HS may be an unreliable measure of TTM severity. 
Construct Validity 
 It was hypothesized that results would provide evidence for convergent validity by 
showing moderate to strong correlations between the MGH-HS and other measures of TTM 
severity (i.e. NIMH-TS and CGI-S). Similarly, it was hypothesized that results would provide 
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evidence for divergent validity by showing low correlations between the MGH-HS and measures 
of anxiety, depression, and quality of life (i.e. BAI, BDI-II, QOLI). 
Results from this study showed a moderate correlation between the MGH-HS and the 
NIMH-TS which is consistent with previous research (Diefenbach et al., 2005) and provides 
additional evidence for convergent validity. Inconsistent with previous research was the low 
correlation between the MGH-HS and the CGI-S which does not provide support for convergent 
validity. One reason for the low correlation between the MGH-HS and the CGI-S could have 
been the difference in experience with hair pulling symptoms between raters. That is, the 
clinician may have compared the participant’s symptoms to other cases while the participant may 
only have themselves as a reference point. Another reason may be differences between 
questionnaires in what is being considered in regards to hair pulling symptoms. For example, the 
MGH-HS asks participants to rate how frequent and distressing hair pulling symptoms have been 
in the past week, while clinicians take into account distress, impairment, and noticeability to 
others when rating the CGI-S. 
Examining the evidence for divergent validity, the MGH-HS showed low correlations 
with the BAI, BDI-II, and QOLI. Previous studies have shown similar correlations for measures 
of anxiety and depression (Diefenbach et al., 2005; O’Sullivan et al., 1995) and evidence for 
divergent validity is expanded further by the addition of the QOLI. 
Given the low and moderate correlations between the MGH-HS and other measures of 
hair pulling severity, evidence for convergent validity is weak overall. However, evidence for 
divergent validity is strong. While it is clear that the MGH-HS is measuring a construct different 
than anxiety, depression, or quality of life, it is unclear how well it is capturing hair pulling 
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severity. Due to the results of this study and the relatively few examinations of construct validity, 
it is important that researchers continue to gather evidence for the validity of the MGH-HS. 
Evaluation of the MGH-HS 
 One interesting result from this study is the continuity of the psychometric properties of 
the MGH-HS with previous findings. Particularly, this study reported the third examination of 
internal consistency which showed an alpha coefficient between the previously reported .80 and 
.89 (Diefenbach et al., 2005; Keuthen et al., 1995). Evidence for convergent validity between the 
MGH-HS and NIMH-TS was replicated (Diefenbach et al. 2005) and evidence for divergent 
validity between the MGH-HS and measures of anxiety and depression were consistent 
(Diefenbach et al. 2005; O’Sullivan et al. 1995). When considered together, the consistency of 
these results allows researchers and clinicians to be increasingly confident in how the MGH-HS 
relates to itself as well as the NIMH-TS and measures of anxiety and depression. 
 Conversely, the MGH-HS demonstrated poor temporal stability as well as a weak 
relationship to the CGI-S. The implication of poor temporal stability is the inability to report 
with confidence, that changes in measurement scores are reflective of an intervention and not 
due to other influencing factors. This causes problems for researchers and clinicians tracking 
changes over time and making inferences about the effectiveness of interventions. Additionally, 
the weak relationship between the MGH-HS and CGI-S raises questions about the validity of the 
MGH-HS even though this is the first study to show this weak relationship. 
 Given the results of this study, it is recommended that the MGH-HS continue to be used, 
but with caution. The recommendation for the continued use of the MGH-HS is due to the 
limited psychometric data available and lack of other measures. First, The MGH-HS is the only 
widely distributed, brief, self-report measure of hair pulling severity for adults with TTM. 
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Second, its continued use allows for a common relationship between past and future studies that 
use the MGH-HS. Lastly, this study is only the second report on the psychometric properties of 
the MGH-HS after the initial development articles. 
Further examinations of the MGH-HS may find increased test-retest reliability over 
shorter time spans and stronger relationships to other measures of hair pulling severity (the two 
problematic results of this study). It is also recommended that future researchers and clinicians 
use the MGH-HS alongside at least one other measure of hair pulling severity to aid in the 
interpretation of changes on the MGH-HS. Researchers and clinicians should be aware that the 
MGH-HS is not a comprehensive questionnaire of all hair pulling symptoms and contains ratings 
of symptoms that some individuals may not have or may not be aware of (i.e. urges to pull hair). 
Future Directions 
 Besides expanding on the psychometric properties of the MGH-HS, researchers and 
clinicians should seek to improve upon current measures or develop new measures. To start, one 
aspect of TTM absent from the MGH-HS is a measure of interference in social, occupational, 
and psychological functioning. In the original development of the MGH-HS, there was an item 
that attempted to measure interference, but was discarded because it did not appear to be 
measuring what was intended. One solution could be to reintroduce a broad question related to 
interference phrased differently than before or with a list of examples. Another solution could be 
to develop a series of questions about specific interfering consequences common to individuals 
with TTM. 
Additionally, the MGH-HS questions individuals about their experience with urges to 
pull hair. In an effort to improve measures of TTM severity, changes in our view of the construct 
of TTM should be reflected in the questions asked about that construct. As discussed earlier, the 
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latest version of the DSM saw the removal of criteria B (an increasing sense of tension) and C 
(pleasure, relief, or gratification when pulling), which refer to urges, from the diagnosis of TTM. 
Due to the recent changes in the DSM 5, and reports that not all individuals with TTM describe 
having urges to pull their hair, questions about urges may be unnecessary for a measure of TTM 
severity. 
Furthermore, many of the available assessment measures of TTM severity have been 
developed based on measures of Obsessive Compulsive Disorder (OCD). This was a logical 
approach given the overlap in presentation of OCD and TTM (i.e. obsessive thoughts 
surrounding hair pulling, perceived inability to avoid performing a behavior, repetitive nature of 
the disorder) and that TTM was once thought to be a variant of OCD (Tynes, White, & Steketee, 
1990). However, researchers have noted significant differences between the two disorders 
(Keuthen, O’Sullivan, & Sprich-Buckminister, 1998) and questioned the utility of OCD-based 
measures of TTM severity (Stanley, Prather, Davis, Wagner, & Swann, 1993; Stanley, 
Breckenridge, Snyder, & Novy, 1999). In response, a measure could be created that takes into 
account the specifics of the disorder to gather a more complete picture of TTM severity. 
To date, a number of suggestions have been made for the improved assessment of TTM 
severity. For example, Stanley et al. (1999) included suggestions for an “ideal” clinician-rated 
measure of TTM severity. It was proposed that, in addition to frequency and duration of hair 
pulling, an assessment of TTM severity should include measurements of situational variables 
(e.g. places hair pulling is likely to occur), affective states (e.g. individual’s mood before, during, 
or after a pulling episode), and sensory stimuli related to hair pulling behavior (e.g. itching at the 
pulling site). Likewise, Diefenbach et al. (2006) proposed developing an assessment along two 
dimensions. The first dimension would assess pulling behaviors such as frequency, duration, and 
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resistance of pulling in the previous week, while the second would assess the impact of pulling 
such as distress, hair loss, and interference. 
Another consideration towards the development of a comprehensive measure of TTM 
severity is the instability of hair pulling symptoms. Although TTM is a chronic disorder, there is 
high variability in its presentation. One approach to improve reliability of a repeated severity 
measurement would be to identify and separate those variables that are relatively constant from 
those that have higher variability. For example, the lengths to which individuals go to conceal 
hair loss or their perceived control over hair pulling may be slow to change or require direct 
intervention to change. In contrast, hair pulling duration and interference can change daily 
depending on situational variables. Changes in these two hypothetical subscales would provide 
information about short and long term fluctuations in hair pulling severity. 
Summary 
This study was designed to expand the literature pertaining to the psychometric properties 
of the MGH-HS. As stated earlier, psychometrics is concerned with the statistical evaluation of 
the usefulness of an assessment instrument. Evidence for the reliability of the MGH-HS has been 
mixed, both in this study and when combined with previous research. Although the MGH-HS 
showed acceptable internal consistency, it was not shown to be stable over repeated 
administrations in the absence of an active intervention. The weak temporal stability of the 
MGH-HS suggests TTM severity may be inherently unstable or the MGH-HS does not fully 
capture the chronic characteristics of the disorder. The largest concern of inadequate reliability is 
the interpretation of treatment gains based on changes in MGH-HS scores. 
The validity of the MGH-HS was also examined and demonstrated acceptable divergent 
validity from measures of anxiety, depression, and quality of life. However, when compared to 
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other measures of TTM severity, the convergent validity of the MGH-HS was shown to be 
inadequate. This suggests the MGH-HS may not be fully capturing a complete picture of TTM 
severity. It is recommended that the MGH-HS continue to be utilized and examined; however, 
caution should be used when interpreting changes in scores on the MGH-HS in both research and 
clinical settings. A multi-assessment approach should be utilized when interpreting results from a 
clinical trial or making clinical decisions. Despite the shortcomings of the MGH-HS, it remains 
an easily administered and brief measure of hair pulling and is the only widely used self-report 
measure available for adults. Future researchers should also consider the development of a new 
self-report measure that takes into account the high variability of hair pulling symptoms. 
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